Washington [US], April 16 (ANI): The Food and Drug Administration (FDA) authorized the first test, InspectIR COVID-19 Breathalyzer, to detect COVID-19 through the breath for emergency use.
A COVID-19 diagnostic test has come to light that uses breath samples to generate a positive or negative result. It has received emergency use authorization from the US Food and Drug Administration (FDA). Dubbed ‘InspectIR’, this breath analyzer COVID-19 test detects chemical components linked to coronavirus in breath samples. “Today’s authorization is yet another example […]
\
\
\
\
